Dose-response relationship also seen for severity of chronic traumatic encephalopathy
THURSDAY, March 3, 2022 (HealthDay News) — There is a dose-response relationship between years of ice hockey play and chronic traumatic encephalopathy (CTE) risk and severity, according to a study scheduled for presentation at the upcoming annual meeting of the American Academy of Neurology, to be held from April 2 to 7 in Seattle.
Bobak Abdolmohammadi, from the Boston University School of Medicine, and colleagues investigated the relationship between years of ice hockey play and the risk for CTE neuropathology at autopsy. The analysis included 74 consecutive brain donors from the Veterans Affairs-Boston University-Concussion Legacy Foundation and Framingham Heart Study Brain Banks, all of whom played ice hockey.
The researchers found that 54 percent of donors were diagnosed with CTE, with a dose-response relationship observed between the duration of ice hockey play and each outcome. Specifically, each additional year of play corresponded to a 23 percent increase in odds for having CTE, a 15 percent increase in odds for increasing one CTE stage, and a 0.03 standard deviation increase in cumulative neurofibrillary tangles burden. When limiting the analysis to those who played hockey as their primary source of exposure (56 donors), the investigators found the results to be similar.
“Previous research has shown a relationship between increasing years of playing football and increased chances of developing chronic traumatic encephalopathy later on, and our results suggest the same is true for ice hockey,” coauthor Jesse Mez, M.D., also from the Boston University School of Medicine, said in a statement.
Brain Abnormalities Identified in Children at Risk for Schizophrenia
Cortical Atrophy in Early-Onset Alzheimer Disease Signature Can Predict Progression to Dementia
Problematic Social Media Use Linked to Worsening of ADHD Symptoms
Docosahexaenoic Acid Supplement Does Not Improve Cognitive Performance
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021
Exercise Link to Dementia Varies by Physical Activity Domain
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy